Status: Recruiting
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients with Short Bowel Syndrome
Participants needed: 40
Trial details
Age: 3-65Biological sex: AllType: InterventionalSponsor: Eclipse Regenesis, Inc.Updated: Oct 8, 2025Locations: 6
Eligibility criteria
Subject has short bowel syndrome, defined as 50% or less of expected bowel lengt... [+4]
Ultra-short bowel syndrome defined as less than 3 cm of bowel length. [+6]